FRCA Notes


Endovascular Aneurysm Repair (EVAR)


  • Endovascular aneurysm repair (EVAR) can be used for elective treatment of abdominal or thoracic ('TEVAR') aneurysms in lieu of an open repair
  • The choice between open repair and EVAR depends on patient factors such as age, co-morbidities and aneurysmal morphology
    • EVAR may be particularly useful for juxta- and supra-renal aneurysms, where the effects of cross-clamping during open repair are more deleterious
    • Ultimately, the decision of open repair vs. EVAR will take place in the MDT setting

  • EVAR can also be used for the emergency management of ruptured AAAs
    • The evidence from multiple trials demonstrates no improvement in 30 day mortality with endovascular vs. open techniques
  • Repair of a simple infra-renal aneurysm involves catheterising the femoral or iliac arteries, or less commonly the brachial or subclavian arteries
    • This can be achieved percutaneously or with a surgical cut-down
  • One or more expandable grafts are then passed into the aorta under fluoroscopic guidance
  • The stent is thus deployed, preventing blood flow into the aneurysmal sac, which will eventually thrombose

  • Juxta- and supra-renal aneurysms require use of fenestrated grafts ('FEVAR') with orifices for the coeliac, superior mesenteric and renal arteries
    • These fenestrated grafts are custom-made following 3D reconstruction of CT angiography
    • More complex grafts lead to longer procedure and fluoroscopy time
    • Patients are therefore submitted to higher doses of iodinated contrast
    • Although carbon dioxide contrast can be used, it carries its own risks e.g. gas embolism and higher radiation doses


Benefits Risks
Less haemodynamic and metabolic physiological disturbance Need for conversion to open procedure (~2%/yr)
Reduced blood loss and need for large transfusion Long-term complications (see below) and need for re-intervention
Avoids short- and long-term complications of laparotomy Lifelong, annual, ultrasound or CT surveillance required
Less pain No decrease in long-term all-cause mortality after 4yrs (EVAR1 study)
Reduced length of stay (ICU and hospital) No long-term survival benefit vs. surveillance in patients unfit for open surgery (EVAR2 study)
Lower 30-day and medium-term mortality (EVAR1)


  • Pre-operative management of patients booked for EVAR is similar to those undergoing open repair

  • EVAR should be carried out in a hybrid theatre (IR facilities with ability to convert to an open procedure if required)
    • The risks associated with remote anaesthesia apply if the procedure is taking place in IR or if hybrid theatres aren't in the main theatre complex

Monitoring

  • Access to the patient is more limited, so sufficient length on monitoring cables and IV lines is required
  • Arterial line insertion should be on the side contralateral to surgical access, in case UL access is needed
  • Large bore IV access is required, though central venous access is reserved for procedures predicted to be long or complicated

Anaesthetic technique

  • No robust evidence for morbidity or mortality benefit of any one anaesthetic technique over another
  • The technique used should be based on patient factors including preference, anticoagulant drugs, ability to lie flat and duration of surgery
  • Breath-holds (i.e. apnoea) are required for brief periods to improve image quality for digital subtraction angiography, so mandatory ventilation is preferable in the patient under GA
  • Neuraxial techniques are acceptable, though intra-operative heparinisation should prompt careful consideration of the timing of removal of epidural catheters
  • Short, simple procedures may even be done under LA

  • Blood loss in simple infra-renal EVAR is ∽200ml
    • This may be greater in more complex and/or longer procedures
    • An unexpected transfusion requirement should prompt suspicion of occult blood loss e.g. groins, retroperitoneal

Early & short-term complications

  • Conversion to an open procedure (2%/yr), with a higher incidence in female patients or smaller patients
  • Arterial rupture or dissection; the highest risk of rupture is during stent deployment
  • Plaque rupture & embolisation
  • Ischaemia of bowel, kidneys or buttocks/legs from prolonged femoral/iliac artery occlusion

  • Spinal cord ischaemia
    • Rare in infra-renal EVAR (0.21%) but higher in complex EVAR, supra-renal EVAR or TEVAR
    • Occlusion of thoracic/lumbar collaterals to the spinal cord, particularly the artery of Adamkiewicz, by stent grafts may impair blood supply
    • High-risk patients may have CSF drained pre-operatively (perfusion pressure = MAP – CSF pressure)

  • Post-implantation syndrome (30 - 40%)
    • A self-limiting, non-infectious rise in temperature, white cell count and CRP
    • Due to endothelial reaction

Long-term complications

  • Endoleak, of which there are five subtypes
  • Infection
  • Graft migration
  • Delayed rupture